Treat-to-Target Urate-lowering Therapy: Lessons Learned from the STOP Gout Study

Current Rheumatology Reports · Published 2026-04-27 · DOI 10.1007/s11926-026-01220-4

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s11926-026-01220-4

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Breaking Barriers: Essential Reforms for a Competitive and Affordable Biosimilars Market · Current Rheumatology Reports · 2025 · Same journal
• Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory Domains · Current Rheumatology Reports · 2025 · Same journal
• Emerging Therapeutics in Rheumatoid Arthritis · Current Rheumatology Reports · 2026 · Same journal
• Juvenile-onset Systemic Lupus Erythematosus: Recent Advances in Pathogenesis and Treatment · Current Rheumatology Reports · 2025 · Same journal
• The Role of Musculoskeletal Ultrasound in Psoriatic Arthritis: From Preclinical Detection to Treatment Monitoring · Current Rheumatology Reports · 2026 · Same journal
• Family Planning and Rheumatoid Arthritis · Current Rheumatology Reports · 2025 · Same journal
• Management of Takayasu Arteritis – A 2026 Update · Current Rheumatology Reports · 2026 · Same journal
• Behçet's Syndrome · Current Rheumatology Reports · 2026 · Same journal
• Unconventional Imaging Methods in Psoriatic Arthritis · Current Rheumatology Reports · 2025 · Same journal
• Advancing Juvenile Spondyloarthritis: Closing Knowledge Gaps with New Axial JSpA Classification Criteria · Current Rheumatology Reports · 2025 · Same journal